Document:

<PAGE>

                                                                   EXHIBIT 10.15

                      EXECUTIVE CHANGE OF CONTROL AGREEMENT

This Agreement is made as of August 23, between Angiotech Pharmaceuticals
(U.S.), Inc., a Washington corporation having an office at Suite 6501,
701 5th Avenue, Seattle, Washington, 98104 ("Angiotech U.S."), Angiotech
Pharmaceuticals, Inc., a British Columbia corporation having an office at
6660 N.W. Marine Drive, Vancouver, British Columbia, V6T 1Z4 (the "Company")
and Jeanne M. Bertonis of 32 Sherwood Road, Melrose, Massachusetts, 02176
(the "Employee").

THIS AGREEMENT WITNESSES:

1.   Definitions - In this Agreement, the following terms shall have the
meanings ascribed below:

(a)  "Change of Control" means:

     (i) a change in the composition of the board of directors of the Company,
     as a result of which fewer than one-half of the incumbent directors are
     directors who had been directors of the Company 12 months prior to such
     change, with the exception of any such change in the composition of the
     board made with the approval of the board as it was constituted immediately
     prior to such change; or

     (ii) the acquisition or aggregation of securities by any Person pursuant to
     which such Person is or becomes the beneficial owner, directly or
     indirectly, of securities of the Company representing 50% or more of the
     combined voting power of the Company's then outstanding base capital stock
     (meaning the securities of the company ordinarily, and apart from rights
     accruing under special circumstances, having the right to vote at elections
     of directors of the Company), except that any change in the relative
     beneficial ownership of the Company's securities by any Person resulting
     solely from a reduction in the aggregate number of outstanding shares of
     base capital stock, and any decrease thereafter in such Person's ownership
     of securities shall be disregarded until such Person increases in any
     manner, directly or indirectly, his, her or its beneficial ownership of any
     securities of the Company; or

     (iii) the acquisition of all or substantially all the capital stock or
     assets of Angiotech U.S. by a Person other than (i) the Company, or (ii) an
     affiliated or related entity of the Company in which a majority of the
     voting stock of such affiliated or related entity is beneficially owned or
     controlled by the Company.

(b)  "Employee Benefit Plans" means such medical, dental, eye care, disability,
life and other health insurance benefit plans maintained, in whole or in part,
by Angiotech U.S. on behalf of employees generally or executive employees over a
certain grade level.

(c)  "Employee Option Plans" means stock option, stock appreciation rights,
restricted stock, phantom stock or similar plans or agreements maintained, in
whole or in part, by the Company on behalf of either employees generally or
executive employees over a certain grade level.

<PAGE>

(d)  "Executive Compensation Programs" means, any compensation programs
maintained, in whole or in part, by Angiotech U.S. on behalf of executive
employees over a certain grade level, including without limitation bonus or
incentive programs tied to the performance of Angiotech U.S.

(e)  "Good Reason" means a material reduction in the authority or responsibility
of the Employee, one or more reductions, in the cumulative amount of 5 percent
or more, in the Base compensation of the Employee or any notification to the
Employee that his or her principal place of work will be relocated by a distance
of 50 miles or more.

(f)  "Person" means any individual, partnership, unincorporated organization or
association, trust, body corporate, government or government agency or
authority, trustee, executor, administrator or other legal representative or
other legal entity whatsoever.

(g)  "Term" means the time period from the effective date of this Agreement
until the employment of the Employee is terminated.

2.   Change of Control - If a Change of Control occurs during the Term, then the
Employee shall become fully vested and receive the maximum of all awards (stock
options and cash bonuses) heretofore or hereafter granted to the Employee under
all employee Option Plans and Executive Compensation Programs, regardless of any
provision in such plans or agreements that do not provide for full vesting.

3.   Rights Upon Termination Due to Change of Control - In addition to any other
rights the Employee may have against Angiotech U.S. and/or the Company, if at
the time of a Change of Control or within twelve (12) months after the
occurrence of a Change of Control, either:

(a)  the employee voluntarily resigns his or her employment for Good Reason; or

(b)  the Company terminates the employee's employment for any reason;

then the Employee shall be entitled to the following payments and benefits:

(c)  an amount equal to the Employee's base annual compensation, payable in one
lump sum within five (5) business days from the termination of the Employee's
employment unless Angiotech U.S. and the Employee agree otherwise in writing;

(d)  an amount equal to the maximum of all awards payable to the employee under
all Executive Compensation Programs pursuant to Section 2, payable in one lump
sum within five (5) business days from the termination of the Employee's
employment unless Angiotech U.S. and the Employee agree otherwise in writing;
and

(e)  during the period commencing on the date when the termination of the
employee's employment is effective and ending on the date twelve (12) months
after such date, the Employee (and, where applicable, the Employee's dependents)
shall be entitled to continue participation in all Employee Benefit Plans
maintained by Angiotech U.S., including without limitation life, disability and
health insurance programs, as if the Employee were still an employee of
Angiotech U.S. Where applicable, the Employee's salary for purposes of such
plans shall be deemed to be equal to the Employee's base annual compensation and
to the extent that Angiotech U.S. finds it impossible to cover the Employee
under its Employee Benefit Plans during the period set out above, Angiotech

                                     Page 2

<PAGE>

U.S. shall provide the Employee with individual policies which offer at least
the same level of coverage and which impose not more than the same costs on the
Employee. In the event the Employee becomes eligible for comparable coverage to
that set out in the Employee Benefit Plans during the period set out above, the
coverage provided under this Paragraph (e) shall terminate immediately.

4.   Gross-Up of Excise Tax Payable by Employee.

(a)  If any payment to or for the benefit of the Employee paid or payable or
distributed or distributable pursuant to the terms of this Agreement (a
"Payment" or "Payments") will be subject to the excise tax imposed by Section
4999 of the Internal Revenue Code of 1986, as amended (the "Code"), or any
interest or penalties are incurred by the Employee with respect to such excise
tax (such excise tax, together with any such interest and penalties, are
hereinafter collectively referred to as the "Excise Tax"), then the Employee
will be entitled to receive an additional payment (a "Gross-Up Payment") in an
amount equal to the Excise Tax imposed upon the Payments and any Excise Tax
imposed upon the Gross-Up Payment.

(b)  An initial determination (the "Determination") as to whether a Gross-Up
Payment is required pursuant to this Agreement and the amount of such Gross-Up
Payment shall be made at the Company's expense by an accounting firm selected by
the Company (the "Accounting Firm"). The Accounting Firm shall provide its
Determination, together with detailed supporting calculations and documentation
to the Company and the Employee within thirty (30) days of the effective date of
the Employee's termination of employment by the Company if applicable, or such
other time as requested by the Company or by the Employee if the Employee
reasonably believes that any of the Payments may be subject to the Excise Tax.
If the Accounting Firm determines that no Excise Tax is payable by the Employee
with respect to a Payment or Payments, it shall furnish the Employee with an
opinion reasonably acceptable to the Employee that no Excise Tax will be imposed
with respect to any such Payment or Payments. The Employee shall have thirty
(30) days to dispute the Determination. The Company shall pay the Gross-Up
Payment, if any, to the Employee within ten (10) days of the receipt of the
Determination, regardless of whether the Employee has disputed the
Determination. Upon the final resolution of a dispute, the Company shall
promptly pay to the Employee any additional amount required by such resolution
and such resolution shall be binding, final and conclusive upon the Company and
the Employee. If there is no dispute, the Determination shall be binding, final
and conclusive upon the Company and the Employee.

(c)  Notwithstanding anything contained in this Agreement to the contrary, in
the event that, according to the Determination, an Excise Tax will be imposed on
any Payment or Payments, the Company shall pay to the applicable government
taxing authorities, as Excise Tax withholding, the amount of the Excise Tax that
the Company withholds from the Payment or Payments.

5.   Miscellaneous Provisions - The following miscellaneous provisions shall
apply to this Agreement:

(a)  Company's Successors. The Company and/or Angiotech U.S., as applicable,
shall require any successor (whether direct or indirect and whether by purchase,
lease, merger, consolidation, liquidation or otherwise) to all or substantially
all of the Company's and/or Angiotech U.S.'s business and/or assets, by an
agreement in substance and form satisfactory to the Employee, to assume this
Agreement and to agree expressly to perform this Agreement in the same manner
and to the same extent as Angiotech U.S. and/or the Company would be required to
perform it in the

                                     Page 3

<PAGE>

absence of a succession. The failure of the Company and/or Angiotech U.S., as
applicable, to obtain such agreement prior to the effectiveness of a succession
shall be a breach of this Agreement and shall entitle the employee to all of the
compensation, benefits and reimbursements to which he or she would have been
entitled hereunder as if there had been a Change of Control and a termination
due to a Change of Control. For all purposes under this Agreement, the term
"Company" and "Angiotech U.S." shall include any successor(s) to the Company's
and/or Angiotech U.S.'s, as applicable, business and/or assets which executes
and delivers the assumption agreement described in this subsection 5(a) or which
becomes bound by this Agreement by operation of law.

(b)  No Assignment. The rights of any person to payments or benefits under this
Agreement shall not be made subject to option or assignment, either by voluntary
or involuntary assignment or by operation of law, including without limitation
by bankruptcy, garnishment, attachment or other creditor's process, and any
action in violation of this Subsection 5(b) shall be void.

(c)  Amendment and Waiver. This Agreement may be amended, modified or
supplemented only by a writing executed by each of the parties. Either party may
in writing waive any provision of this Agreement to the extent such provision is
for the benefit of the waiving party. No waiver by either party of a breach of
any provision of this Agreement shall be construed as a waiver of any subsequent
or different breach, and no forbearance by a party to seek a remedy for
noncompliance or breach by the other party shall be construed as a waiver of any
right or remedy with respect to such noncompliance or breach.

(d)  Employee's Successors. This Agreement and all rights of Employee hereunder
shall inure to the benefit of and be binding upon the Employee's heirs and legal
personal representatives.

(e)  Governing Law, Venue. This Agreement shall be governed by the laws of the
State of Washington without regard to its conflicts of laws rules. The parties
hereby agree the venue for all matters and actions arising under this Agreement
shall be and remain exclusivity in the state and federal courts sitting in King
County, Washington, and the parties hereby irrevocably consent to the personal
jurisdiction of such courts. The prevailing party shall be entitled to
reasonable attorneys' fees and costs incurred in connection with any such
litigation arising under or related to this Agreement.

(f)  Severability. If any provision of this Agreement is held to be invalid or
unenforceable to any extent in any context, it shall nevertheless be enforced to
the fullest extent allowed by law in that and other contexts, and the validity
and force of the remainder of this Agreement shall not be affected thereby.

(g)  Notice. All notices and other communications under this Agreement shall be
in writing and shall be given by personal or courier delivery, facsimile or
first class mail, certified or registered with return receipt requested, and
shall be deemed to have been duly given upon receipt if personally delivered or
delivered by courier, on the date of transmission if transmitted by facsimile,
or three days after mailing if mailed, to the addresses of the Company and the
Employee contained in the records of the Company at the time of such notice. Any
party may change such party's address for notices by notice duly given pursuant
to this Section 5(g).

(h)  Headings, Pronouns. The Section and other headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. Any and all uses of masculine or
feminine pronouns herein are solely to aid in the ease

                                     Page 4

<PAGE>

of reading this Agreement and any such pronoun usage shall have equal
application to the members of the opposite gender.

IN WITNESS WHEREOF each of the parties has executed this Agreement, in the case
of the company by its duly authorized officer, as of the day and year first
stated above.

ANGIOTECH PHARMACEUTICALS (U.S.), INC.         EMPLOYEE:

By: /s/ Donald E. Longenecker                  /s/ Jeanne M. Bertonis
    ----------------------------------         ---------------------------------
    Donald E. Longenecker                      Jeanne M. Bertonis
    Dated: August 23, 2001                     Dated: August 23, 2001

ANGIOTECH PHARMACEUTICALS, INC.

By: /s/ William L. Hunter
    ----------------------------------
    William L. Hunter
    Dated: August 23, 2001

                                     Page 5Daktronics, Inc, Exhibit 4.5

                                                                     EXHIBIT 4.5

                                DAKTRONICS, INC.
                        2002 EMPLOYEE STOCK PURCHASE PLAN
                                TABLE OF CONTENTS

1.       PURPOSE OF THE PLAN...................................................1

2.       ADMINISTRATION OF THE PLAN............................................1

         2.1.     COMMITTEE COMPOSITION........................................1
         2.2.     COMMITTEE RESPONSIBILITIES...................................1
         2.3      PLAN YEAR....................................................1

3.       ENROLLMENT AND PARTICIPATION..........................................1

         3.1.     OFFERING PERIODS.............................................1
         3.2.     CONTRIBUTION PERIODS.........................................1
         3.3.     ENROLLMENT...................................................1
         3.4.     DURATION OF PARTICIPATION....................................2
         3.5      APPLICABLE OFFERING PERIOD...................................2

4.       EMPLOYEE CONTRIBUTIONS................................................2

         4.1.     FREQUENCY OF PAYROLL DEDUCTIONS..............................2
         4.2.     AMOUNT OF PAYROLL DEDUCTIONS.................................2
         4.3.     CHANGING WITHHOLDING RATE....................................3
         4.4      DISCONTINUING PAYROLL DEDUCTIONS.............................3

5.       WITHDRAWAL FROM THE PLAN..............................................3

         5.1.     WITHDRAWAL...................................................3
         5.2.     RE-ENROLLMENT AFTER WITHDRAWAL...............................3

6.       CHANGE IN EMPLOYMENT STATUS...........................................3

         6.1.     TERMINATION OF EMPLOYMENT....................................3
         6.2.     DEATH........................................................3

7.       PLAN ACCOUNTS AND PURCHASE OF SHARES..................................4

         7.1.     PLAN ACCOUNTS................................................4
         7.2.     PURCHASE PRICE...............................................4
         7.3.     NUMBER OF SHARES PURCHASED...................................4
         7.4.     AVAILABLE SHARES INSUFFICIENT................................4
         7.5.     ISSUANCE OF COMMON STOCK CERTIFICATES........................4
         7.6.     RESTRICTED RESALE OF SHARES ACQUIRED UNDER PLAN..............5
         7.7.     UNUSED CASH BALANCES.........................................5
         7.8.     STOCKHOLDER APPROVAL.........................................5

                                        i

8.       LIMITATIONS ON STOCK OWNERSHIP........................................5

         8.1.     FIVE PERCENT LIMIT...........................................5
         8.2.     DOLLAR LIMIT.................................................5

9.       RIGHTS NOT TRANSFERABLE...............................................6

10.      NO RIGHTS AS AN EMPLOYEE..............................................6

11.      NO RIGHTS AS A STOCKHOLDER............................................6

12.      SECURITIES LAW REQUIREMENTS...........................................6

13.      STOCK OFFERED UNDER THE PLAN..........................................6

         13.1.    AUTHORIZED SHARES............................................6
         13.2.    ANTI-DILUTION ADJUSTMENTS....................................7
         13.3.    REORGANIZATIONS..............................................7

14.      AMENDMENT OR DISCONTINUANCE...........................................7

15.      DEFINITIONS...........................................................7

         15.1.    "BOARD"......................................................7
         15.2.    "CHANGE IN CONTROL"..........................................7
         15.3.    "CODE".......................................................8
         15.4.    "COMMITTEE"..................................................8
         15.5.    "COMMON STOCK"...............................................8
         15.6.    "CONTRIBUTION PERIOD"........................................8
         15.7.    "CORPORATION"................................................8
         15.8.    "COMPENSATION"...............................................8
         15.9.    "ELIGIBLE EMPLOYEE"..........................................8
         15.10.   "EXCHANGE ACT"...............................................9
         15.11.   "FAIR MARKET VALUE"..........................................9
         15.12.   "OFFERING PERIOD"............................................9
         15.13.   "PARTICIPANT"................................................9
         15.14.   "PARTICIPATING CORPORATION"..................................9
         15.15.   "PLAN".......................................................9
         15.16.   "PLAN ACCOUNT"...............................................9
         15.17.   "PURCHASE PRICE"............................................10
         15.18.   "SUBSIDIARY"................................................10

16.      GOVERNING LAW........................................................10

17.      EXECUTION............................................................10

                                       ii

                                DAKTRONICS, INC.
                        2002 EMPLOYEE STOCK PURCHASE PLAN

1.       PURPOSE OF THE PLAN

The Plan was adopted by the Board on June 25, 2002, to be effective as of
November 1, 2002. The purpose of the Plan is to provide Eligible Employees with
an opportunity to increase their proprietary interest in the success of the
Corporation by purchasing Common Stock from the Corporation on favorable terms
and to pay for such purchases through payroll deductions. The Plan is intended
to qualify under Section 423 of the Code.

2.       ADMINISTRATION OF THE PLAN

         2.1.     COMMITTEE COMPOSITION.
                  The Board or Compensation Committee shall oversee the Plan.
                  (For purposes of this Plan, references hereinafter to the
                  Committee shall mean either the Compensation Committee or the
                  Board.)

         2.2.     COMMITTEE RESPONSIBILITIES.
                  The Committee shall interpret the Plan and make all other
                  policy decisions relating to the operation of the Plan. The
                  Committee may adopt such rules, guidelines and forms as it
                  deems appropriate to implement the Plan. The Committee's
                  determinations under the Plan shall be final and binding on
                  all persons. The Committee shall act by majority vote of its
                  members. An action of the Committee may be taken without a
                  meeting by a unanimous written consent signed by all members
                  of the Committee.

         2.3.     PLAN YEAR.
                  The Plan Year shall consist of a twelve month period
                  commencing on May 1 and ending on April 30.

3.       ENROLLMENT AND PARTICIPATION

         3.1.     OFFERING PERIODS.
                  While the Plan is in effect, options to purchase shares of
                  Common Stock shall be offered to Participants under the Plan
                  through a continuous series of Offering Periods, each
                  continuing for six months, and each of which shall commence on
                  May 1 and November 1 of each year (the "Offering Date") and
                  shall terminate on October 31 and April 30 of each year (the
                  "Termination Date"). Offering Periods under the Plan shall
                  continue until either (A) the Committee decides that no
                  further Offerings shall be made because the Common Stock
                  remaining available under the Plan is insufficient to make an
                  Offering to all Eligible Employees or (B) the Plan is
                  terminated in accordance with Section 14 below.

         3.2.     CONTRIBUTION PERIODS.
                  While the Plan is in effect, two Contribution Periods shall
                  commence in each calendar year. The Contribution Periods shall
                  consist of the six-month periods commencing on each May 1 and
                  ending on October 31 and commencing on November 1 and ending
                  on April 30.

         3.3.     ENROLLMENT.
                  Participation in the Plan by an Eligible Employee is
                  voluntary. Any individual who, on the day prior to the first
                  day of an Offering Period, qualifies as an Eligible Employee
                  may elect to become a Participant in the Plan for such
                  Offering Period by executing the enrollment form prescribed
                  for this purpose by the Committee. The enrollment form shall
                  be filed with the Corporation at the prescribed location not
                  later than ten business days prior to the commencement of such
                  Offering Period.

                                        1

         3.4.     DURATION OF PARTICIPATION.
                  Once enrolled in the Plan, a Participant shall continue to
                  participate in the Plan until he or she ceases to be an
                  Eligible Employee, withdraws from the Plan under Section 5.1
                  or reaches the end of the Contribution Period in which his or
                  her employee contributions were discontinued under Section 4.4
                  or 8.2. A Participant who discontinued employee contributions
                  under Section 4.4 or withdrew from the Plan under Section 5.1
                  may again become a Participant, if he or she then is an
                  Eligible Employee, by following the procedure described in
                  Section 3.3 above. A Participant whose employee contributions
                  were discontinued automatically under Section 8.2 shall
                  automatically resume participation at the beginning of the
                  earliest Contribution Period ending in the next calendar year,
                  if he or she then is an Eligible Employee.

         3.5.     APPLICABLE OFFERING PERIOD.
                  For purposes of calculating the Purchase Price under Section
                  7.2, the applicable Offering Period shall be determined as
                  follows:

                  3.5.1.   Once a Participant is enrolled in the Plan for an
                           Offering Period, such Offering Period shall continue
                           to apply to him or her until the earliest of (A) the
                           end of such Offering Period or (B) the end of his or
                           her participation under Section 3.4 above.

                  3.5.2.   Each Participant who actively contributed to the plan
                           on the last pay date of an offering period is
                           automatically re-enrolled in the following offering
                           period. Employees who withdraw or change their
                           deferrals to 0% during an offering period must submit
                           a new enrollment form to participate in a future
                           offering period.

4.       EMPLOYEE CONTRIBUTIONS

         4.1.     FREQUENCY OF PAYROLL DEDUCTIONS.
                  A Participant may purchase shares of Common Stock under the
                  Plan solely by means of payroll deductions. Payroll
                  deductions, as designated by the Participant pursuant to
                  Section 4.2 below, shall occur on each payday during
                  participation in the Plan and shall be determined based upon
                  the Payroll Withholding Rate designated by the Participant
                  pursuant to Section 4.2 below. Payroll deductions for a
                  Participant shall be on an after-tax basis and shall begin
                  with the first payroll on or following the applicable Offering
                  Date and shall continue until the termination date of the
                  Plan, subject to earlier termination as provided herein or to
                  decreases by the Participant in the amount of the Payroll
                  Withholding Rate as provided in Section 4.3.

         4.2.     AMOUNT OF PAYROLL DEDUCTIONS.
                  An Eligible Employee shall designate on the enrollment form
                  the portion of his or her Compensation that he or she elects
                  to have withheld for the purchase of Common Stock (the
                  "Payroll Withholding Rate"). Such portion shall be a
                  percentage of the Eligible Employee's Compensation, but not
                  more than 15% or such lesser percentage established by the
                  Committee from time to time. In no event may a Participant
                  contribute more than 15% of his or her Compensation during a
                  calendar year for the purchase of shares of Common Stock under
                  the Plan.

                                        2

         4.3.     CHANGING WITHHOLDING RATE.
                  No increases in the Payroll Withholding Rate may be made
                  during an Offering Period. A Participant may elect to make one
                  decrease in the Payroll Withholding Rate during an Offering
                  Period, which change shall become effective as soon as
                  reasonably practical after a new enrollment form has been
                  received by the Corporation. Otherwise, if a Participant
                  wishes to change the Payroll Withholding Rate, he or she may
                  do so by filing a new enrollment form with the Corporation at
                  the prescribed location not less than ten business days before
                  the Offering Date as of which such increase or decrease is to
                  be effective. The new Payroll Withholding Rate shall be a
                  percentage of the Participant's Compensation, not more than
                  15%.

         4.4.     DISCONTINUING PAYROLL DEDUCTIONS.
                  If a Participant wishes to discontinue employee contributions
                  entirely, he or she may do so by filing a new enrollment form
                  with the Corporation at the prescribed location at any time.
                  Payroll withholding shall cease as soon as reasonably
                  practicable after such form has been received by the
                  Corporation. (In addition, employee contributions may be
                  discontinued automatically pursuant to Section 8.2.) A
                  Participant who has discontinued employee contributions may
                  resume such contributions by filing a new enrollment form with
                  the Corporation pursuant to Section 3.3 above.

5.       WITHDRAWAL FROM THE PLAN

         5.1.     WITHDRAWAL.
                  A Participant may elect to withdraw from the Plan by filing
                  the prescribed form with the Corporation at the prescribed
                  location at any time before the last day of a Contribution
                  Period. As soon as reasonably practicable thereafter, payroll
                  deductions shall cease, and the entire amount credited to the
                  Participant's Plan Account shall be refunded to him or her in
                  cash, without interest. No partial withdrawals shall be
                  permitted.

         5.2.     RE-ENROLLMENT AFTER WITHDRAWAL.
                  A former Participant who has withdrawn from the Plan shall not
                  be a Participant until he or she re-enrolls in the Plan under
                  Section 3.3. Re-enrollment may be effective only at the
                  commencement of an Offering Period.

6.       CHANGE IN EMPLOYMENT STATUS

         6.1.     TERMINATION OF EMPLOYMENT.
                  Termination of employment as an Eligible Employee for any
                  reason, including death, shall be automatically treated as a
                  withdrawal from the Plan under Section 5.1. (A transfer from
                  one Participating Corporation to another shall not be treated
                  as a termination of employment.)

         6.2.     DEATH.
                  In the event of the Participant's death, the amount credited
                  to his or her Plan Account shall be paid to a beneficiary
                  designated by him or her for this purpose on the prescribed
                  form or, if none, to the Participant's estate. Such form shall
                  be valid only if it was filed with the Corporation at the
                  prescribed location before the Participant's death.

                                        3

7.       PLAN ACCOUNTS AND PURCHASE OF SHARES

         7.1.     PLAN ACCOUNTS.
                  The Corporation shall maintain a Plan Account on its books in
                  the name of each Participant. Whenever an amount is deducted
                  from the Participant's Compensation under the Plan, such
                  amount shall be credited to the Participant's Plan Account.
                  Amounts credited to Plan Accounts shall not be trust funds and
                  may be commingled with the Corporation's general assets and
                  applied to general corporate purposes. A Participant may not
                  make any separate cash payment or contribution to his or her
                  Plan Account. No interest shall be credited to Plan Accounts.

         7.2.     PURCHASE PRICE.
                  The Purchase Price for each share of Common Stock purchased at
                  the Termination Date of an Offering Period shall be the lower
                  of:

                  7.2.1.   85% of the Fair Market Value of such share on the
                           last trading day in such Offering Period; or

                  7.2.2.   85% of the Fair Market Value of such share on the
                           last trading day before the Offering Date.

         7.3.     NUMBER OF SHARES PURCHASED.
                  As of the Termination Date of each Offering Period, each
                  Participant shall be deemed to have elected to purchase the
                  number of shares of Common Stock calculated in accordance with
                  this Section 7.3, unless the Participant's participation has
                  terminated, through withdrawal or otherwise, in accorandance
                  with Section 5.1 or Section 6. The amount then in the
                  Participant's Plan Account shall be divided by the Purchase
                  Price, and the whole number of shares that results shall be
                  purchased from the Corporation with the funds in the
                  Participant's Plan Account. The foregoing notwithstanding, no
                  Participant shall purchase more than 4,000 shares of Common
                  Stock with respect to any Contribution Period nor more than
                  the amounts of Common Stock set forth in Sections 8.2 and
                  13.1. Notwithstanding the foregoing, the Committee may
                  determine with respect to all Participants that any fractional
                  share, as calculated under this Section 7.3, shall be (i)
                  rounded down to the next lower whole share or (ii) credited as
                  a fractional share.

         7.4.     AVAILABLE SHARES INSUFFICIENT.
                  In the event that the aggregate number of shares that all
                  Participants are to purchase on any Termination Date exceeds
                  the maximum number of shares remaining available for issuance
                  under Section 13.1, then the number of shares to which each
                  Participant is entitled shall be determined by multiplying the
                  number of shares available for issuance by a fraction, the
                  numerator of which is the number of shares that such
                  Participant has elected to purchase on the Termination Date
                  and the denominator of which is the number of shares that all
                  Participants have elected to purchase on the Termination Date.
                  In such event, the Corporation shall give written notice of
                  such reduction of the number of shares subject to the option
                  to each Participant affected thereby.

         7.5.     ISSUANCE OF COMMON STOCK CERTIFICATES.
                  Certificates representing the shares of Common Stock purchased
                  by a Participant under the Plan shall be issued to him or her
                  as soon as reasonably practicable after the Termination Date
                  of each Offering Period, except that the Committee may
                  determine that such shares shall be held for each
                  Participant's benefit by a broker designated by the Committee
                  (unless the Participant has elected that certificates be

                                        4

                  issued directly to him or her). Shares may be registered in
                  the name of the Participant or jointly in the name of the
                  Participant and his or her spouse as joint tenants with right
                  of survivorship or as community property. The Committee may
                  impose such restrictions on the transfer or resale of issued
                  shares as it may deem advisable.

         7.6.     RESTRICTED RESALE OF SHARES ACQUIRED UNDER PLAN.
                  Notwithstanding anything else set forth herein, shares of
                  Common Stock acquired under this Plan may not be resold or
                  transferred for a period of one year after the date of
                  purchase. Certificates for shares issued under this Plan shall
                  contain an appropriate legend identifying such restriction on
                  resale.

         7.7.     UNUSED CASH BALANCES.
                  An amount remaining in the Participant's Plan Account that
                  represents the Purchase Price for any fractional share shall
                  be carried over in the Participant's Plan Account to the next
                  Offering Period. Any amount remaining in the Participant's
                  Plan Account that represents the Purchase Price for whole
                  shares that could not be purchased by reason of Section 7.4
                  above, Section 8.2 or Section 13.1 shall be refunded to the
                  Participant in cash, without interest.

         7.8.     STOCKHOLDER APPROVAL.
                  Any other provision of the Plan notwithstanding, no shares of
                  Common Stock shall be purchased under the Plan unless and
                  until the Corporation's stockholders have approved the
                  adoption of the Plan.

8.       LIMITATIONS ON STOCK OWNERSHIP

         8.1.     FIVE PERCENT LIMIT.
                  Any other provision of the Plan notwithstanding, no
                  Participant shall be granted a right to purchase Common Stock
                  under the Plan if such Participant, immediately after his or
                  her election to purchase such Common Stock, would own stock
                  possessing more than 5% of the total combined voting power or
                  value of all classes of stock of the Corporation or any parent
                  or Subsidiary of the Corporation. For purposes of this Section
                  8.1, the following rules shall apply:

                  8.1.1.   Ownership of stock shall be determined after applying
                           the attribution rules of section 424(d) of the Code;

                  8.1.2.   Each Participant shall be deemed to own any stock
                           that he or she has a right or option to purchase
                           under this or any other plan; and

                  8.1.3.   Each Participant shall be deemed to have the right to
                           purchase no more than 4,000 shares of Common Stock
                           under this Plan with respect to each Offering Period.

         8.2.     DOLLAR LIMIT.
                  Any other provision of the Plan notwithstanding, no
                  Participant shall acquire a right purchase Common Stock which
                  permits his rights to purchase stock under all "employee
                  purchase plans (as such term is defined in Section 423 of the
                  Code) of the Corporation and its parent and Subsidiary
                  corporations to accrue at a rate which exceeds $25,000 of the
                  Fair Market Value of such stock (determined at the time the
                  right was granted) for each calendar year in which such right
                  is outstanding at any time.

                                        5

                  For purposes of this Section 8.2, the Fair Market Value of
                  Common Stock shall be determined in each case as of the
                  Offering Date of the Offering Period in which such Common
                  Stock is purchased. Employee stock purchase plans not
                  described in section 423 of the Code shall be disregarded. If
                  a Participant is precluded by this Section 8.2 from purchasing
                  additional Common Stock under the Plan, then his or her
                  employee contributions shall automatically be discontinued and
                  shall resume at the beginning of the earliest Contribution
                  Period ending in the next calendar year (if he or she then is
                  an Eligible Employee).

9.       RIGHTS NOT TRANSFERABLE

The rights of any Participant under the Plan, or any Participant's interest in
any Common Stock or moneys to which he or she may be entitled under the Plan,
shall not be transferable by voluntary or involuntary assignment or by operation
of law, or in any other manner other than by beneficiary designation, will or
the laws of descent and distribution. If a Participant in any manner attempts to
transfer, assign or otherwise encumber his or her rights or interest under the
Plan, other than by beneficiary designation, will or the laws of descent and
distribution, then such act shall be treated as an election by the Participant
to withdraw from the Plan under Section 5.1.

10.      NO RIGHTS AS AN EMPLOYEE

Nothing in the Plan or in any right granted under the Plan shall confer upon the
Participant any right to continue in the employ of a Participating Corporation
for any period of specific duration or interfere with or otherwise restrict in
any way the rights of the Participating Corporations or of the Participant,
which rights are hereby expressly reserved by each, to terminate his or her
employment at any time and for any reason, with or without cause.

11.      NO RIGHTS AS A STOCKHOLDER

A Participant shall have no rights as a stockholder with respect to any shares
of Common Stock that he or she may have a right to purchase under the Plan until
such shares have been purchased on the Termination Date of the applicable
Offering Period.

Even if the right to purchase shares is granted hereunder to a Participant, this
does not mean that the Participant remains further entitled to purchase Common
Stock. Such right to purchase Common Stock is granted voluntarily by the Company
and may be revoked by the Company at any time.

12.      SECURITIES LAW REQUIREMENTS

Shares of Common Stock shall not be issued under the Plan unless the issuance
and delivery of such shares comply with (or are exempt from) all applicable
requirements of law, including (without limitation) the Securities Act of 1933,
as amended, the rules and regulations promulgated thereunder, state securities
laws and regulations, and the regulations of any stock exchange or other
securities market on which the Corporation's securities may then be traded.

13.      STOCK OFFERED UNDER THE PLAN

         13.1.    AUTHORIZED SHARES.
                  The aggregate number of shares of Common Stock to be reserved
                  by the Company and available for purchase under the Plan shall
                  be 500,000.

                                        6

         13.2.    ANTI-DILUTION ADJUSTMENTS.
                  The aggregate number of shares of Common Stock offered under
                  the Plan, the number of shares by which the share reserve is
                  to increase each calendar year, the 4,000-share limitation
                  described in Section 7.3 and the price of shares that any
                  Participant has elected to purchase shall be adjusted
                  proportionately by the Committee for any increase or decrease
                  in the number of outstanding shares of Common Stock resulting
                  from a subdivision or consolidation of shares or the payment
                  of a stock dividend, any other increase or decrease in such
                  shares effected without receipt or payment of consideration by
                  the Corporation, the distribution of the shares of a
                  Subsidiary to the Corporation's stockholders or a similar
                  event.

         13.3.    REORGANIZATIONS.
                  Any other provision of the Plan notwithstanding, immediately
                  prior to the effective time of a Change in Control, the
                  Offering Period and Contribution Period then in progress shall
                  terminate and shares shall be purchased pursuant to Section 7.
                  In the event of a merger or consolidation to which the
                  Corporation is a constituent corporation and which does not
                  constitute a Change in Control, the Plan shall continue unless
                  the plan of merger or consolidation provides otherwise. The
                  Plan shall in no event be construed to restrict in any way the
                  Corporation's right to undertake a dissolution, liquidation,
                  merger, consolidation or other reorganization.

14.      AMENDMENT OR DISCONTINUANCE

The Plan may be amended by the Board from time to time to the extent that the
Board deems necessary or appropriate in light of, and consistent with, Section
423 of the Code; provided, however, that no such amendment shall be effective
without approval of the shareholders of the Corporation if shareholder approval
of such amendment is then required under Rule 16b-3 under the Exchange Act or
any successor rule or Section 423 of the Code or any other applicable law or
regulation.. The Board shall have the right to amend, suspend or terminate the
Plan at any time and without notice; provided, however, that the Board shall not
have the right to modify, cancel or amend any outstanding right to purchase
Common Stock hereunder before such termination unless each Participant consents
in writing.

15.      DEFINITIONS

         15.1.    "BOARD"
                  Means the Board of Directors of the Corporation, as
                  constituted from time to time.

         15.2.    "CHANGE IN CONTROL"
                  Means:

                  15.2.1.  The consummation of a merger or consolidation of the
                           Corporation with or into another entity or any other
                           corporate reorganization, if more than 50% of the
                           combined voting power of the continuing or surviving
                           entity's securities outstanding immediately after
                           such merger, consolidation or other reorganization is
                           owned by persons who were not stockholders of the
                           Corporation immediately prior to such merger,
                           consolidation or other reorganization;

                  15.2.2.  The sale, transfer or other disposition of all or
                           substantially all of the Corporation's assets;

                  15.2.3.  A change in the composition of the Board as a result
                           of which fewer than two-thirds of the incumbent
                           directors are directors who either (i) had been
                           directors of the Corporation on the date 24 months
                           prior to the date of the event that may constitute a
                           Change in Control (the "original directors") or (ii)
                           were elected, or nominated for election, to the Board
                           with the affirmative votes of at least a majority of

                                        7

                           the aggregate of the original directors who were
                           still in office at the time of the election or
                           nomination and the directors whose election or
                           nomination was previously so approved; or

                  15.2.4.  Any transaction as a result of which any person is
                           the "beneficial owner" (as defined in Rule 13d-3
                           under the Exchange Act), directly or indirectly, of
                           securities of the Corporation representing at least
                           50% of the total voting power represented by the
                           Corporation's then outstanding voting securities. For
                           purposes of this Section 15.2.2 , the term "person"
                           shall have the same meaning as when used in sections
                           13(d) and 14(d) of the Exchange Act but shall exclude
                           (i) a trustee or other fiduciary holding securities
                           under an employee benefit plan of the Corporation or
                           of a Parent or Subsidiary and (ii) a corporation
                           owned directly or indirectly by the stockholders of
                           the Corporation in substantially the same proportions
                           as their ownership of the common stock of the
                           Corporation.

                           A transaction shall not constitute a Change in
                           Control if its sole purpose is to change the state of
                           the Corporation's incorporation or to create a
                           holding company that will be owned in substantially
                           the same proportions by the persons who held the
                           Corporation's securities immediately before such
                           transaction.

         15.3.    "CODE"
                  Means the Internal Revenue Code of 1986, as amended.

         15.4.    "COMMITTEE"
                  Means the Compensation Committee of the Board, as described in
                  Section 2.

         15.5.    "COMMON STOCK"
                  Means the common stock of the Corporation.

         15.6.    "CONTRIBUTION PERIOD"
                  Means a six-month period during which contributions may be
                  made toward the purchase of Common Stock under the Plan, as
                  determined pursuant to Section 3.2.

         15.7.    "CORPORATION"
                  Means Daktronics, Inc., a South Dakota corporation.

         15.8.    "COMPENSATION"
                  Means (i) the total compensation paid in cash to a Participant
                  by a Participating Corporation, including salaries, wages,
                  bonuses, incentive compensation, commissions, overtime pay and
                  shift premiums, plus (ii) any pre-tax contributions made by
                  the Participant under section 401(k) or 125 of the Code.
                  "Compensation" shall exclude all non-cash items, moving or
                  relocation allowances, cost-of-living equalization payments,
                  car allowances, tuition reimbursements, imputed income
                  attributable to cars or life insurance, severance pay, fringe
                  benefits, contributions or benefits received under employee
                  benefit plans, income attributable to the exercise of stock
                  options, and similar items. The Committee shall determine
                  whether a particular item is included in Compensation,
                  determined in a manner consistent with the requirements of
                  Section 423 of the Code.

         15.9.    "ELIGIBLE EMPLOYEE"
                  Means any employee of a Participating Corporation whose
                  customary employment is for more than five months per calendar
                  year and for more than 20 hours per week provided that such
                  employee has been employed by any Participating Corporation
                  for a continuous period of six (6) months preceding an
                  applicable Offering Period.

                                        8

         15.10.   "EXCHANGE ACT"
                  Means the Securities Exchange Act of 1934, as amended.

         15.11.   "FAIR MARKET VALUE"
                  Means the market price of Common Stock, determined by the
                  Committee as follows:

                  15.11.1.   If the Common Stock was traded over-the-counter on
                             the date in question but was not traded on The
                             Nasdaq National Market or The Nasdaq SmallCap
                             Market, then the Fair Market Value shall be equal
                             to the mean between the last reported
                             representative bid and asked prices quoted for such
                             date by the principal automated inter-dealer
                             quotation system on which the Common Stock was
                             quoted or, if the Common Stock was not quoted on
                             any such system, by the "Pink Sheets" published by
                             Pink Sheets LLC;

                  15.11.2.   If the Common Stock was traded over-the-counter
                             market on the date in question and was traded on
                             The Nasdaq National Market or The Nasdaq SmallCap
                             Market, then the Fair Market Value shall be equal
                             to the last-transaction price quoted for such date
                             by The Nasdaq National Market or The Nasdaq
                             SmallCap Market;

                  15.11.3.   If the Common Stock was traded on a stock exchange
                             on the date in question, then the Fair Market Value
                             shall be equal to the closing price reported by the
                             applicable composite transactions report for such
                             date; or

                  15.11.4.   If none of the foregoing provisions is applicable,
                             then the Fair Market Value shall be determined by
                             the Committee in good faith on such basis as it
                             deems appropriate. Whenever possible, the
                             determination of Fair Market Value by the Committee
                             shall be based on the prices reported in THE WALL
                             STREET JOURNAL or as reported directly to the
                             Corporation by Nasdaq or a stock exchange. Such
                             determination shall be conclusive and binding on
                             all persons.

         15.12.   "OFFERING PERIOD"
                  Means a six-month period with respect to which the right to
                  purchase Common Stock may be granted under the Plan, as
                  determined pursuant to Section 3.1.

         15.13.   "PARTICIPANT"
                  Means an Eligible Employee who elects to participate in the
                  Plan, as provided in Section 3.3.

         15.14.   "PARTICIPATING CORPORATION"
                  Means (i) the Corporation and (ii) each present or future
                  Subsidiary designated by the Committee as a Participating
                  Corporation.

         15.15.   "PLAN"
                  Means this Daktronics, Inc. 2002 Employee Stock Purchase Plan,
                  as it may be amended from time to time.

         15.16.   "PLAN ACCOUNT"
                  Means the account established for each Participant pursuant to
                  Section 7.1.

                                        9

         15.17.   "PURCHASE PRICE"
                  Means the price at which Participants may purchase Common
                  Stock under the Plan, as determined pursuant to Section 7.2.

         15.18.   "SUBSIDIARY"
                  Means any corporation (other than the Corporation) in an
                  unbroken chain of corporations beginning with the Corporation,
                  if each of the corporations other than the last corporation in
                  the unbroken chain owns stock possessing 50% or more of the
                  total combined voting power of all classes of stock in one of
                  the other corporations in such chain.

16.      GOVERNING LAW

The Plan shall be construed consistent with and governed by the laws of the
State of South Dakota and the laws of the United States.

17.      EXECUTION

To record the adoption of the Plan as of 25 June 2002, the Corporation has
caused its authorized officer to execute the same.

                                        DAKTRONICS, INC.

                                        By:  /s/ James B. Morgan
                                             -----------------------------------
                                                 James B. Morgan

                                        Title:   Chief Executive Officer
                                                 -------------------------------

                                       10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]